Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinisches Magazin
Erschienen in:

28.02.2024 | Hämatologie

Klassifikation der Hodgkin-Lymphome und verwandter Entitäten

Neuigkeiten und offene Fragen

verfasst von: Prof. Dr. Sylvia Hartmann, Prof. Dr. Falko Fend

Erschienen in: Wiener klinisches Magazin | Ausgabe 5-6/2024

Einloggen, um Zugang zu erhalten

Zusammenfassung

Vor kurzem sind 2 neue Lymphomklassifikationen, die 5. Edition der WHO-Klassifikation hämatolymphoider Tumoren und die „International Consensus Classification“ (ICC) des Clinical Advisory Committee, erschienen. Im Rahmen der Vorbereitung beider Klassifikationen wurden die bestehenden Lymphomentitäten erneut diskutiert und im Licht der in der letzten Zeit hinzugewonnenen klinischen, morphologischen und molekularen Daten reevaluiert. In diesem Review fassen wir die aktuelle Einordnung des klassischen und nodulären lymphozytenprädominanten Hodgkin-Lymphoms sowie die relevanten Differenzialdiagnosen zusammen.
Vorheriger Artikel Mukoviszidose im Kindes- und im Erwachsenenalter
Literatur
1.
Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720–1748PubMedPubMedCentralCrossRef
2.
Asano N, Yamamoto K, Tamaru J et al (2009) Age-related Epstein-Barr virus (EBV)-associated B‑cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 113:2629–2636PubMedCrossRef
3.
4.
Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140:1229–1253PubMedPubMedCentralCrossRef
5.
Chute DJ, Cousar JB, Mahadevan MS et al (2008) Detection of immunoglobulin heavy chain gene rearrangements in classic hodgkin lymphoma using commercially available BIOMED‑2 primers. Diagn Mol Pathol 17:65–72PubMedCrossRef
6.
Dojcinov SD, Fend F, Quintanilla-Martinez L (2018) EBV-positive lymphoproliferations of B‑ T‑ and NK-cell derivation in non-immunocompromised hosts. Pathogens 7:28PubMedPubMedCentralCrossRef
7.
Dojcinov SD, Venkataraman G, Pittaluga S et al (2011) Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 117:4726–4735PubMedPubMedCentralCrossRef
8.
Dojcinov SD, Venkataraman G, Raffeld M et al (2010) EBV positive mucocutaneous ulcer—a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34:405–417PubMedPubMedCentralCrossRef
9.
Eberle FC, Rodriguez-Canales J, Wei L et al (2011) Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin’s lymphoma and primary mediastinal large B‑cell lymphoma. Haematologica 96:558–566PubMedPubMedCentralCrossRef
10.
Fan Z, Natkunam Y, Bair E et al (2003) Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346–1356PubMedCrossRef
11.
Hartmann S, Doring C, Jakobus C et al (2013) Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma—endpoints of a spectrum of one disease? Plos One 8:e78812PubMedPubMedCentralCrossRef
12.
Hartmann S, Doring C, Vucic E et al (2015) Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma. Br J Haematol 169:415–422PubMedCrossRef
13.
Hartmann S, Eichenauer DA, Plutschow A et al (2013) The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 122:4246–4252PubMedCrossRef
14.
Hartmann S, Goncharova O, Portyanko A et al (2019) CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma. Mod Pathol 32:37–47PubMedCrossRef
15.
16.
Hartmann S, Schuhmacher B, Rausch T et al (2016) Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia 30:844–853PubMedCrossRef
17.
Hartmann S, Soltani AS, Bankov K et al (2022) Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma. Br J Haematol 199:382–391PubMedCrossRef
18.
19.
Jackson H Jr., Parker F Jr. (1946) Hodgkin’s disease; clinical diagnosis. N Engl J Med 234:37–41PubMedCrossRef
20.
Jackson H Jr., Parker F Jr. (1946) Hodgkin’s disease; treatment and prognosis. N Engl J Med 234:103–110PubMedCrossRef
21.
Jaffe ES, Harris NL, Stein H et al (2001) WHO classification of tumors: pathology and genetics of tumors of Haematopoietic and lymphoid tissues. IARC Press, Lyon
22.
Joos S, Granzow M, Holtgreve-Grez H et al (2003) Hodgkin’s lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 103:489–495PubMedCrossRef
23.
Joos S, Menz CK, Wrobel G et al (2002) Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 99:1381–1387PubMedCrossRef
24.
Küppers R (2003) B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 3:801–812PubMedCrossRef
25.
Küppers R, Rajewsky K, Zhao M et al (1994) Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 91:10962–10966PubMedPubMedCentralCrossRef
26.
Lake A, Shield LA, Cordano P et al (2009) Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases. Int J Cancer 125:1334–1342PubMedCrossRef
27.
Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin’s disease. Cancer Res 26:1063–1083PubMed
28.
Nicolae A, Pittaluga S, Abdullah S et al (2015) EBV-positive large B‑cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood 126:863–872PubMedPubMedCentralCrossRef
29.
Overkamp M, Quintanilla-Martinez L, Fend F (2022) EBV-associated lymphoproliferative disorders. Pathologie 43:282–291PubMedCrossRef
30.
Oyama T, Yamamoto K, Asano N et al (2007) Age-related EBV-associated B‑cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 13:5124–5132PubMedCrossRef
31.
Pittaluga S, Nicolae A, Wright GW et al (2020) Gene expression profiling of mediastinal gray zone lymphoma and its relationship to primary mediastinal B‑cell lymphoma and classical Hodgkin lymphoma. Blood Cancer Discov 1:155–161PubMedPubMedCentralCrossRef
32.
Poppema S, Kaiserling E, Lennert K (1979) Hodgkin’s disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres—a cytohistological study. Histopathology 3:295–308PubMedCrossRef
33.
Poppema S, Kaiserling E, Lennert K (1979) Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol 31:211–225PubMedCrossRef
34.
Quintanilla-Martinez L, Fend F, Moguel LR et al (1999) Peripheral T‑cell lymphoma with Reed-Sternberg-like cells of B‑cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 23:1233–1240PubMedCrossRef
35.
Reichel J, Chadburn A, Rubinstein PG et al (2015) Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood 125:1061–1072PubMedCrossRef
36.
Rudiger T, Jaffe ES, Delsol G et al (1998) Workshop report on Hodgkin’s disease and related diseases (’grey zone‘ lymphoma). Ann Oncol 9(Suppl 5):S31–S38PubMedCrossRef
37.
Sarkozy C, Hung SS, Chavez EA et al (2021) Mutational landscape of gray zone lymphoma. Blood 137:1765–1776PubMedCrossRef
38.
Schmitz R, Hansmann ML, Bohle V et al (2009) TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 206:981–989PubMedPubMedCentralCrossRef
39.
Schuhmacher B, Bein J, Rausch T et al (2019) JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T‑cell/histiocyte-rich large B‑cell lymphoma. Haematologica 104:330–337PubMedPubMedCentralCrossRef
40.
41.
Slack GW, Ferry JA, Hasserjian RP et al (2009) Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis. Leuk Lymphoma 50:937–943PubMedCrossRef
42.
Tiacci E, Ladewig E, Schiavoni G et al (2018) Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood 131:2454–2465PubMedPubMedCentralCrossRef
43.
Tousseyn TA, King RL, Fend F et al (2023) Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities. Virchows Arch 482:207–226PubMedCrossRef
44.
Traverse-Glehen A, Pittaluga S, Gaulard P et al (2005) Mediastinal gray zone lymphoma: the missing link between classic Hodgkin’s lymphoma and mediastinal large B‑cell lymphoma. Am J Surg Pathol 29:1411–1421PubMedCrossRef
45.
46.
47.
Xia D, Sayed S, Moloo Z et al (2022) Geographic variability of nodular lymphocyte-predominant Hodgkin lymphoma. Am J Clin Pathol 157:231–243PubMedCrossRef
Metadaten
Titel
Klassifikation der Hodgkin-Lymphome und verwandter Entitäten
Neuigkeiten und offene Fragen
verfasst von
Prof. Dr. Sylvia Hartmann
Prof. Dr. Falko Fend
Publikationsdatum
28.02.2024
Verlag
Springer Vienna
Erschienen in
Wiener klinisches Magazin / Ausgabe 5-6/2024
Print ISSN: 1869-1757
Elektronische ISSN: 1613-7817
DOI
https://doi.org/10.1007/s00740-024-00523-5

Weitere Artikel der Ausgabe 5-6/2024

Panorama

  • Panorama

Mukoviszidose im Kindes- und im Erwachsenenalter

  • Pulmologie

Anwendung von künstlicher Intelligenz in der onkologischen Chirurgie des oberen Gastrointestinaltrakts

  • Chirurgie

Mehr Poesie!

  • Editorial